REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) › Net IncomeREVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) — Net IncomeAnnual figures by fiscal year, from SEC filings.2019: -$846.8K2020: -$3.78M2021: -$8.52M2022: -$28.26M2023: -$39.26M2024: -$29.92M2025: -$19.86M-$19.86M2019Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$19.86M+33.6%2024-$29.92M+23.8%2023-$39.26M-38.9%2022-$28.26M-231.6%2021-$8.52M-125.2%2020-$3.78M-346.8%2019-$846.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share